288 related articles for article (PubMed ID: 23738435)
21. Diagnosis and treatment of presymptomatic Wilson's disease.
Walshe JM
Lancet; 1988 Aug; 2(8608):435-7. PubMed ID: 2900362
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
23. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
24. [Wilsons disease].
Mareček Z; Brůha R
Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
[TBL] [Abstract][Full Text] [Related]
26. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
Brewer GJ
Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
[TBL] [Abstract][Full Text] [Related]
27. Wilson's disease: an update, with emphasis on new approaches to treatment.
Brewer GJ; Yuzbasiyan-Gurkan V
Dig Dis; 1989; 7(4):178-93. PubMed ID: 2663256
[No Abstract] [Full Text] [Related]
28. Treatment and management of Wilson's disease.
Shimizu N; Yamaguchi Y; Aoki T
Pediatr Int; 1999 Aug; 41(4):419-22. PubMed ID: 10453198
[TBL] [Abstract][Full Text] [Related]
29. [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
Palumbo E
Recenti Prog Med; 2008 Nov; 99(11):561-4. PubMed ID: 19209540
[TBL] [Abstract][Full Text] [Related]
30. [Wilson disease in 2003].
Szalay F
Orv Hetil; 2003 Dec; 144(50):2451-8. PubMed ID: 15067983
[TBL] [Abstract][Full Text] [Related]
31. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
Serra B; Primo J; García M; Amorós I; Aragó M; Merino C
Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
[TBL] [Abstract][Full Text] [Related]
32. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
33. Wilson's disease: overview.
Lucena-Valera A; Ruz-Zafra P; Ampuero J
Med Clin (Barc); 2023 Mar; 160(6):261-267. PubMed ID: 36697289
[TBL] [Abstract][Full Text] [Related]
34. Wilson's disease in pregnancy.
Nunns D; Hawthorne B; Goulding P; Maresh M
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):141-3. PubMed ID: 7493698
[TBL] [Abstract][Full Text] [Related]
35. [Wilson's disease: physiopathological, clinical and therapeutic considerations].
Pérez-Aguilar F
Gastroenterol Hepatol; 2003 Jan; 26(1):42-51. PubMed ID: 12525328
[No Abstract] [Full Text] [Related]
36. [Wilson's disease and its pharmacological treatment].
Hayashi H; Suzuki R; Wakusawa S
Yakugaku Zasshi; 2004 Nov; 124(11):711-24. PubMed ID: 15516801
[TBL] [Abstract][Full Text] [Related]
37. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
38. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
39. Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
Jacquelet E; Poujois A; Pheulpin MC; Demain A; Tinant N; Gastellier N; Woimant F
J Inherit Metab Dis; 2021 Nov; 44(6):1481-1488. PubMed ID: 34480375
[TBL] [Abstract][Full Text] [Related]
40. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
